In summary, Bcl-xL and Bcl2 are key mediators of apoptosis [48] and may represent promising therapeutic targets for colorectal cancer (CRC) treatment, as demonstrated by our experimental results. The gene discussed is BCL2L1; the disease is colorectal cancer.